Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Heart Failure VII: Nursing Interventions

Heart Failure VII: Nursing Interventions

The first step in nursing management of a patient with heart failure involves thoroughly assessing the patient's medical history.Subjective Data: Obtain the patient's medical history of coronary artery disease, hypertension, myocardial infarction, and symptoms like dyspnea, orthopnea, and paroxysmal nocturnal dyspnea.Objective Data: Conduct a physical examination to identify findings such as jugular vein distention, pulmonary crackles, tachycardia, murmurs, peripheral edema, and vital signs,...

Heart Failure VI: Adjunct Therapies

Heart Failure VI: Adjunct Therapies

Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.

Heart Failure III: Clinical Manifestations

Heart Failure III: Clinical Manifestations

Heart failure (HF) manifests primarily as dyspnea, fatigue, and fluid retention, resulting in peripheral and pulmonary edema. Symptoms may vary depending on which ventricle is more affected, left or right.Left-Sided Heart FailureAlso known as left ventricular failure, this condition results from the left ventricle's inability to fill or eject sufficient blood into the systemic circulation. It leads to pulmonary congestion, which occurs when the left ventricle fails to eject blood effectively...

Heart Failure II: Pathophysiology

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...

Heart Failure I: Introduction

Heart Failure I: Introduction

Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...

Pathophysiology of Heart Failure

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Overview of findings from the UK and Ireland National Advanced Heart Failure Audit 2024.

Open heart·2026

Same author

Rising Up to Meet our Patients on their Diagnostic and Treatment Odysseys.

Journal of cardiac failure·2026

Same author

Burden, Impact, and Priorities in Amyloidosis: Findings from the International Amyloid Patient Experiences Survey (AMPES).

Journal of cardiac failure·2026

Same author

Perspectives on the 2026 ISHLT Consensus Statement on Clinical Cardiac Xenotransplantation.

The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation·2026

Same author

The 2026 International Society for Heart and Lung Transplantation Consensus Statement on clinical cardiac xenotransplantation.

The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation·2026

Same author

Consolidating Concepts From Recent International Expert Consensus on Sarcopenia: Implications for Heart Failure Management.

Journal of cardiac failure·2025

Search research articles

Related Experiment Videos

Frailty in Advanced Heart Failure.

¹Section of Heart Failure and Cardiac Transplant Medicine, Robert and Suzanne Tomsich Department of Cardiovascular Medicine, Sydell and Arnold Miller Family Heart and Vascular Institute, Cleveland Clinic Foundation, 9500 Euclid Avenue, J3-4, Cleveland, OH 44195, USA.

Heart Failure Clinics

|July 3, 2016

Summary

Frailty, a syndrome of impaired physiological reserve, is common in advanced heart failure (HF) patients. It significantly impacts outcomes after interventions, offering prognostic insights beyond traditional risk assessments.

Keywords:

Advanced heart failure Cachexia Frailty Fried phenotype Left ventricular assist device Sarcopenia

Related Experiment Videos

Area of Science:

Gerontology
Cardiology
Clinical Medicine

Background:

Frailty is a biological syndrome characterized by reduced physiological reserve and increased susceptibility to stressors.
The aging population with heart failure (HF) and increased use of mechanical circulatory support highlight the growing clinical relevance of frailty.
Current understanding of frailty's impact on advanced HF patient outcomes is limited.

Purpose of the Study:

To assess the prevalence of frailty in patients with advanced heart failure.
To determine if frailty provides prognostic information beyond conventional risk assessment tools in this population.

Main Methods:

Review of existing literature on frailty in advanced heart failure.
Analysis of data on frailty prevalence and its association with post-intervention outcomes.

Main Results:

Frailty is highly prevalent among patients with advanced heart failure.
Frailty appears to offer prognostic value not captured by traditional risk assessment methods.

Conclusions:

Frailty is a significant clinical consideration in the management of advanced heart failure.
Further research is warranted to elucidate the role of frailty in predicting outcomes for patients with advanced heart failure, particularly those undergoing mechanical circulatory support.